| PACKAGING |

Boosting Functionality of Container Closures

Closures that protect solid-dosage drugs and the capping equipment that applies them have new product-protecting features.
/ read more /

| 2018 BIO/PHARMA OUTLOOK |

Forecasting Bio/Pharma in 2018

Brexit-related challenges cast shadows on prospects for the European bio/pharma market in 2018, but optimism may let some sun shine through.
/ read more /

| FORMULATION |

Tackling the Opioid Crisis with Abuse-Deterrent Formulations

Abuse-deterrent opioid formulations generally fall into two categories: the first is based on a physiochemical abuse-deterrent approach and the second combines the opioid with an antagonist.
/ read more /

| FLUID HANDLING |

Selecting and Installing Peristaltic Pump Tubing

Proper selection and installation optimizes fluid system performance.
/ read more /

| ELEMENTAL IMPURITIES |

Determination of Dermal PDE for Pharmaceutical Products

The authors offer recommendations for permissible daily exposures and concentration limits of elemental impurities for dermal drug products.
/ read more /

| INTERNET OF THINGS |

Pharma Equipment Gets Smart

The Industrial Internet of Things can be used in the bio/pharmaceutical industry to monitor equipment health, optimize processes, and enable modular facilities.
/ read more /

| QUALITY |

Process Validation in Biologics Development

Process validation is an extension of biologics development processes.
/ read more /

| SERIALIZATION |

Pharma Serialization Nears a Tipping Point

Everyone may not be ready for the deadline, but open standards based on GAMP and GS1 will soon be released; more companies are also leveraging what they’ve learned from serialization to improve overall efficiency.
/ read more /

| PEER-REVIEWED RESEARCH |

Removing Subjectivity from the Assessment of Critical Process Parameters and Their Impact

A new algorithm uses a statistical approach to critical process parameter assessment, allowing for faster, more consistent, and less subjective critical process parameter quantification, visualization, and documentation.
/ read more /

| EU REGULATORY WATCH |

Pharma Braces Itself for Post-Brexit Regulatory Changes

The repercussions of EMA’s relocation and Brexit will continue to be the dominant regulatory issue throughout 2018.
/ read more /

| US REGULATORY WATCH |

Drug Pricing and Quality Are Top Issues for 2018

Policy makers look to boost generic drugs, curb opioid abuse, and maintain incentives for innovation.
/ read more /

| OUTSOURCING |

What to Watch for in 2018

The industry will see an impact from financing, M&As, advanced therapies, generic drugs, and the retail market in 2018.
/ read more /

| ASK THE EXPERT |

Meeting Data Integrity Requirements

Enterprise-wide processes, procedures, and systems are the keys to data integrity and peace of mind, according to Siegfried Schmitt, PhD, principal consultant at PAREXEL.
/ read more /